Related Experiment Videos
[Vitamin K for newborn infants: why and how?]
1Kinderklinik der Thüringen-Klinik Georgius Agricola Saalfeld gGmbH.
Kinderarztliche Praxis
|October 1, 1993
Summary
Vitamin K deficiency in newborns is confirmed by PIVKA II detection. Oral vitamin K prophylaxis is recommended over intramuscular injections due to potential risks.
Area of Science:
- Biochemistry
- Neonatal Medicine
- Public Health
Context:
- Vitamin K deficiency bleeding (VKDB) remains a concern in newborns.
- Acarboxyprothrombin (PIVKA II) is a reliable biomarker for vitamin K deficiency.
- Epidemiological data highlight the incidence of VKDB.
Purpose:
- To review evidence supporting vitamin K prophylaxis in newborns.
- To compare the safety and efficacy of different vitamin K administration routes.
- To address concerns regarding intramuscular vitamin K injections.
Summary:
- Elevated PIVKA II levels in newborns indicate vitamin K deficiency.
- Both intramuscular and oral vitamin K are effective in preventing hemorrhages.
- Intramuscular injections may be linked to increased cancer risk, warranting caution.
Impact:
- Recommends oral vitamin K administration as the preferred prophylactic method for newborns.
- Suggests limiting intramuscular injections to exceptional cases.
- Emphasizes the importance of continued vitamin K prophylaxis for infant health.